4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-030300
Chief Scientific Officer sold 77,700 shares at an average $36.85 ($2,863,365)
- Chief Scientific Officer acquired 77,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…